Development, validation, and initial results of the Angioedema Activity Score

Weller, Karsten; Groffik, A.; Magerl, Markus; Tohme, N.; Martus, Peter; Krause, Karoline; Metz, Martin; Staubach, Petra; Maurer, Marcus

doi:10.1111/all.12209

Cited by 139 publications

(139 citation statements)

References 22 publications

Supporting

Mentioning

125

Contrasting

Unclassified

Order By: Relevance

“…Günlük değerlendirme amacıyla kullanılabileceği gibi, yedi günlük Anjiyoödem Aktivite Skoru (AAS) (AAS7) ve 28 günlük (AAS28) olarak kullanılabilmektedir 120 .…”

Section: Anjiyoödem Aktivite Skoruunclassified

Disease severity scoring systems in dermatology

Bilaç¹,

Şahin²,

Öztürkcan³

2016

TURKDERM

View full text Add to dashboard Cite

Scoring systems have been developed to interpret the disease severity objectively by evaluating the parameters of the disease. Body surface area, visual analogue scale, and physician global assessment are the most frequently used scoring systems for evaluating the clinical severity of the dermatological diseases. Apart from these scoring systems, many specific scoring systems for many dermatological diseases, including acne (acne vulgaris, acne scars), alopecia (androgenetic alopecia, tractional alopecia), bullous diseases (autoimmune bullous diseases, toxic epidermal necrolysis), dermatitis (atopic dermatitis, contact dermatitis, dyshidrotic eczema), hidradenitis suppurativa, hirsutismus, connective tissue diseases (dermatomyositis, skin involvement of systemic lupus erythematosus (LE), discoid LE, scleroderma), lichen planoplaris, mastocytosis, melanocytic lesions, melasma, onychomycosis, oral lichen planus, pityriasis rosea, psoriasis (psoriasis vulgaris, psoriatic arthritis, nail psoriasis), sarcoidosis, urticaria, and vitiligo, have also been developed. Disease severity scoring methods are ever more extensively used in the field of dermatology for clinical practice to form an opinion about the prognosis by determining the disease severity; to decide on the most suitable treatment modality for the patient; to evaluate the efficacy of the applied medication; and to compare the efficiency of different treatment methods in clinical studies. Keywords: Disease severity, scoring system, dermatology Skorlama sistemleri, hastalığa ait parametrelerin değerlendirilerek hastanın klinik şiddetini objektif olarak saptama amacıyla geliştirilmiş olan ölçeklerdir. Vücut yüzey alanı, görsel analog skala ve doktor global değerlendirme skoru dermatolojik hastalıkların klinik şiddetinin değerlendirilmesi amacıyla en sık kullanılan genel skorlama sistemleridir. Bu skorlama sistemleri dışında akne (akne vulgaris, akne skarları), alopesi (androgenetik alopesi, traksiyonel alopesi), Behçet hastalığı, büllöz hastalıklar (otoimmün büllöz hastalıklar, toksik epidermal nekroliz, epidermolizis bülloza), dermatit (atopik dermatit, kontakt dermatit, dishidrotik egzama), hidradenitis suppurativa, hirsutismus, konnektif doku hastalıkları (dermatomyozit, sistemik lupus eritematozusun (LE) deri tutulumu, diskoid LE, skleroderma), liken planopilaris, mastositoz, melanositik lezyonlar-melanom, melazma, mikozis fungoides/Sezary sendromu, onikomikoz, oral liken planus, pitiriyazis rozea, psoriasis (psoriasis vulgaris, psoriatik artrit, tırnak psoriasisi), sarkoidoz, ürtiker ve anjiyoödem ve vitiligo gibi çok sayıda dermatolojik hastalık için spesifik skorlama sistemleri de geliştirilmiştir. Hastalık şiddet skorlama yöntemleri, dermatoloji alanında klinik pratikte hastalığın şiddetinin belirlenerek prognoz hakkında fikir sahibi olunabilmesi, hasta için uygun tedavinin belirlenmesi, uygulanan tedavinin etkinliğinin değerlendirilmesi, klinik araştırmalarda ise farklı tedavi yöntemlerinin etkinliklerinin karşılaştırılabilmesi gibi amaçlarla giderek d...

show abstract

“…Günlük değerlendirme amacıyla kullanılabileceği gibi, yedi günlük Anjiyoödem Aktivite Skoru (AAS) (AAS7) ve 28 günlük (AAS28) olarak kullanılabilmektedir 120 .…”

Section: Anjiyoödem Aktivite Skoruunclassified

Disease severity scoring systems in dermatology

Bilaç¹,

Şahin²,

Öztürkcan³

2016

TURKDERM

View full text Add to dashboard Cite

show abstract

“…AAS28 allows the patients to evaluate the influence of these attacks on physical burden, daily activity and outward appearance, which can further describe the personal attack burden (112). However, in study IV, the number of attack days can explain almost as much of the impairment in HR-QoL as AAS28.…”

Section: Hr-qol In Hae Adultsmentioning

confidence: 99%

“…In this study, we used the instruments EQ-5D-5L, RAND-36, AE-QoL, and AAS (107,109,110,112). The EQ-5D-5L has been described above.…”

Section: Study IVmentioning

confidence: 99%

“…The score was categorized into four levels, no (0), low (1-25), moderate , and high . This four-graded scale was modified from the study that validated AAS (112).…”

Section: Study IVmentioning

confidence: 99%

“…Pain is missing in the AE-QoL, but is covered by the EQ-5D-5L and RAND-36 (107,109,112). Thus, in painful HAE attacks, the AE-QoL will not capture this aspect of impairment in HR-QoL.…”

Section: Differences Between Hr-qol Instrumentsmentioning

confidence: 99%

See 2 more Smart Citations